AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic Steatohepatitis

Inclusion Criteria: * Male or female, 18 to 75 years of age * Overweight or obese with a body mass index (BMI) ≥ 25 kg/m2 * Presumed NASH based on clinical characteristics or prior liver biopsy * ALT ≥ 43 IU/L for men and ≥ 28 IU/L for women * MRI-cT1 value\> 800 ms * Written informed consent Exclusion Criteria: * History or clinical evidence of chronic liver diseases other than NAFLD * History or clinical evidence of cirrhosis, hepatic decompensation or other severe liver impairment * History of liver transplant, or current placement on a liver transplant list * Weight loss of \> 5% total body weight within 3 months prior to Screening Note: Other protocol-defined inclusion/exclusion criteria could apply.